midazolam and ro 48-6791

midazolam has been researched along with ro 48-6791 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albrecht, S; Hering, W; Ihmsen, H; Schüttler, J; Schwilden, H1
Cohen, AF; Dingemanse, J; Massarella, J; Oberyé, JJ; Roncari, G; Schoemaker, RC; Segala, P; van Gerven, JM; van Oostenbruggen, MF; Zell, M1
Cohen, AF; Schoemaker, RC; van Gerven, JM1
Gold, J; Gold, M; Tang, J; Wang, B; White, PF1
Ahonen, J; Olkkola, KT1

Reviews

1 review(s) available for midazolam and ro 48-6791

ArticleYear
Midazolam and other benzodiazepines.
    Handbook of experimental pharmacology, 2008, Issue:182

    Topics: Anesthetics, Intravenous; Animals; Benzodiazepines; Biotransformation; Central Nervous System; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Flumazenil; Humans; Lorazepam; Midazolam; Molecular Structure; Receptors, GABA-A; Structure-Activity Relationship

2008

Trials

3 trial(s) available for midazolam and ro 48-6791

ArticleYear
[RO 48-6791--a short acting benzodiazepine. Pharmacokinetics and pharmacodynamics in young and old subjects in comparison to midazolam].
    Der Anaesthesist, 1996, Volume: 45, Issue:12

    Topics: Adjuvants, Anesthesia; Adult; Aged; Aging; Anti-Anxiety Agents; Benzodiazepines; Cross-Over Studies; Double-Blind Method; Electroencephalography; Female; Humans; Male; Midazolam; Middle Aged; Retrospective Studies

1996
Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    British journal of clinical pharmacology, 1997, Volume: 44, Issue:5

    Topics: Adjuvants, Anesthesia; Adult; Anti-Anxiety Agents; Benzodiazepines; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Humans; Infusions, Intravenous; Male; Midazolam

1997
Comparison of the sedation and recovery profiles of Ro 48-6791, a new benzodiazepine, and midazolam in combination with meperidine for outpatient endoscopic procedures.
    Anesthesia and analgesia, 1999, Volume: 89, Issue:4

    Topics: Adjuvants, Anesthesia; Ambulatory Care; Analgesics, Opioid; Anesthesia Recovery Period; Anti-Anxiety Agents; Benzodiazepines; Dizziness; Double-Blind Method; Drug Combinations; Endoscopy, Gastrointestinal; Female; Humans; Hypnotics and Sedatives; Injections, Intravenous; Length of Stay; Male; Meperidine; Midazolam; Middle Aged; Psychomotor Performance; Time Factors; Wakefulness; Walking

1999

Other Studies

1 other study(ies) available for midazolam and ro 48-6791

ArticleYear
Estimating potency for the Emax-model without attaining maximal effects.
    Journal of pharmacokinetics and biopharmaceutics, 1998, Volume: 26, Issue:5

    Topics: Adjuvants, Anesthesia; Anti-Anxiety Agents; Benzodiazepines; Dose-Response Relationship, Drug; Linear Models; Midazolam; Oxazoles; Pharmacology; Saccades; Toxicology

1998